Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01961687 · ClinicalTrials.gov registry record · NA
A Prospective, Multi-Center Study of Phasix™ Mesh for Ventral or Incisional Hernia Repair.
A NA study of Ventral Hernia and Incisional Hernia, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 121
- Enrollment target
- 16
- Study locations
NCT01961687 is a NA study of Ventral Hernia and Incisional Hernia that has completed, run by C. R. Bard. The registered enrollment target is 121 participants, below the 136-participant average among 18 other Ventral Hernia trials with a reported enrollment target (11% lower). The trial reports 16 study locations across 12 states.
The verdict
NCT01961687, a NA study of Ventral Hernia and Incisional Hernia, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
- 16
- Study locations
Study Summary
Single-arm study of Phasix Mesh in High Risk patients looking at SSI and recurrence rates.
Conditions Studied
Interventions
- DEVICE Resorbable Mesh
Study Locations (16)
Tennessee
- Univerity of Tennessee Health Science Center - Germantown
- University of Tennessee Health Sciences Center - Knoxville
- Vanderbilt University Medical Center - Nashville
Massachusetts
- Baystate Medical Center - Springfield
- University of Massachusetts Worcester - Worcester
Wisconsin
- University of Wisconsin System - Madison
- Medical College of Wisconsin - Milwaukee
California
- University of California, San Diego - San Diego
Florida
- Florida Hospital/Celebration Health - Celebration
Illinois
- NorthShore University HealthSystem - Evanston
Indiana
- Indiana University - Indianapolis
Kentucky
- University of Kentucky Medical Center - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2013-09 |
| Est. Completion | 2020-01-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01961687
The ClinicalTrials.gov registry entry for NCT01961687 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 136-participant average among 18 other Ventral Hernia trials with a reported enrollment target (11% lower). The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Ventral Hernia appearing as the primary indexed condition, and to 1 intervention - of which Resorbable Mesh is the first listed.
NCT01961687 reports 16 study locations spanning 12 distinct geographic areas - top geographies include Tennessee, Massachusetts, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT01961687 about?
NCT01961687 is a clinical study titled "A Prospective, Multi-Center Study of Phasix™ Mesh for Ventral or Incisional Hernia Repair.". Single-arm study of Phasix Mesh in High Risk patients looking at SSI and recurrence rates.
What is the current status of trial NCT01961687?
This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2013-09. Estimated completion is 2020-01-27.
What conditions does trial NCT01961687 study?
This clinical trial studies the following conditions: Ventral Hernia, Incisional Hernia.
What interventions are being tested in trial NCT01961687?
The interventions under investigation include: Resorbable Mesh (DEVICE).
Who is sponsoring clinical trial NCT01961687?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01961687 being conducted?
This trial has 16 study locations across California, Florida, Illinois, Indiana, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventral Hernia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair
RECRUITING · NA
-
Robotic Versus Open Ventral Hernia Repair
RECRUITING · NA
-
Clinical Investigation of the da Vinci Surgical System
ACTIVE NOT RECRUITING · NA
-
Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Hernia Surgery (Enable Hernia Repair)
ACTIVE NOT RECRUITING · NA
-
Pilot Trial of Abdominal Core Rehabilitation To Improve Outcomes After Ventral Hernia Repair
ACTIVE NOT RECRUITING · NA
-
CYP2D6 Genotype-guided Management of Opioid Analgesics in Patients Undergoing Elective Ventral Hernia Repairs
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.